Stoke Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 08/07/2026 | 5.88 M | $192.31 M | 9.13% | 8.90% |
| RTW INVESTMENTS, LP | 08/14/2026 | 5.62 M | $184.00 M | 0.00% | 8.52% |
| FMR LLC | 08/13/2026 | 5.31 M | $173.84 M | -1.31% | 8.05% |
| LYNX1 CAPITAL MANAGEMENT LP | 08/13/2026 | 4.04 M | $132.14 M | -15.23% | 6.12% |
| REDMILE GROUP, LLC | 08/14/2026 | 3.95 M | $129.11 M | -5.24% | 5.98% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 3.52 M | $115.15 M | 13.68% | 5.33% |
| MORGAN STANLEY | 08/13/2026 | 3.45 M | $112.98 M | 0.86% | 5.23% |
| BAKER BROS. ADVISORS LP | 08/14/2026 | 3.34 M | $109.18 M | 0.00% | 5.05% |
| TORONTO DOMINION BANK | 08/14/2026 | 3.17 M | $103.83 M | 0.00% | 4.81% |
| STATE STREET CORP | 08/07/2026 | 2.85 M | $93.33 M | 25.29% | 4.32% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 2.66 M | $87.09 M | 37.62% | 4.03% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 2.59 M | $84.64 M | 9.82% | 3.92% |
| BVF INC/IL | 08/14/2026 | 2.55 M | $83.36 M | 0.00% | 3.86% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2026 | 2.42 M | $79.02 M | 862.54% | 3.66% |
| SIREN, L.L.C. | 08/13/2026 | 2.00 M | $65.29 M | 0.00% | 3.02% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 08/14/2026 | 1.82 M | $59.66 M | 0.00% | 2.76% |
| JUPITER TOPCO LLC | 08/14/2026 | 1.81 M | $59.36 M | 100.00% | 2.75% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 1.52 M | $49.88 M | 15.28% | 2.31% |
| ASSENAGON ASSET MANAGEMENT S.A. | 08/21/2026 | 1.13 M | $36.92 M | 24.41% | 1.71% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 1.01 M | $33.17 M | 2.42% | 1.54% |
| POLAR CAPITAL HOLDINGS PLC | 08/14/2026 | 833.72 K | $27.28 M | -26.38% | 1.26% |
| ECOR1 CAPITAL, LLC | 08/14/2026 | 735.00 K | $24.05 M | 635.00% | 1.11% |
| BIOIMPACT CAPITAL LLC | 08/14/2026 | 723.31 K | $23.67 M | -5.70% | 1.10% |
| OPALEYE MANAGEMENT INC. | 08/14/2026 | 700.00 K | $22.90 M | 0.00% | 1.06% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 575.34 K | $18.83 M | -30.74% | 0.87% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 566.99 K | $18.55 M | 22.54% | 0.86% |
| BAILLIE GIFFORD & CO | 08/06/2026 | 517.28 K | $16.93 M | -10.07% | 0.78% |
| NORTHERN TRUST CORP | 08/13/2026 | 500.12 K | $16.36 M | 15.87% | 0.76% |
| TROLUCE CAPITAL ADVISORS LLC | 08/14/2026 | 496.42 K | $16.24 M | -23.96% | 0.75% |
| FIRST TRUST ADVISORS LP | 08/11/2026 | 490.91 K | $16.06 M | 200.33% | 0.74% |
| CITADEL ADVISORS LLC | 09/02/2026 | 489.30 K | $16.01 M | 297.73% | 0.74% |
| CANDRIAM S.C.A. | 08/13/2026 | 480.14 K | $15.69 M | -4.36% | 0.73% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 467.01 K | $15.28 M | 6.83% | 0.71% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 467.01 K | $15.28 M | 100.00% | 0.71% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 08/14/2026 | 461.61 K | $15.10 M | 37.55% | 0.70% |
| ERSTE ASSET MANAGEMENT GMBH | 07/28/2026 | 428.38 K | $13.88 M | -3.95% | 0.65% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 402.50 K | $13.17 M | 12.76% | 0.61% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2026 | 355.44 K | $11.63 M | 5.62% | 0.54% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 08/13/2026 | 355.15 K | $11.62 M | 12.57% | 0.54% |
| JANE STREET GROUP, LLC | 08/14/2026 | 331.70 K | $10.85 M | 415.47% | 0.50% |
| TANG CAPITAL MANAGEMENT LLC | 08/14/2026 | 300.00 K | $9.82 M | -40.00% | 0.45% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 261.03 K | $8.54 M | -44.71% | 0.40% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 259.71 K | $8.50 M | -52.18% | 0.39% |
| JPMORGAN CHASE & CO | 08/12/2026 | 259.35 K | $8.48 M | -2.31% | 0.39% |
| UBS GROUP AG | 08/13/2026 | 207.11 K | $6.78 M | 30.83% | 0.31% |
| BIRCHVIEW CAPITAL, LP | 08/14/2026 | 178.11 K | $5.83 M | -15.19% | 0.27% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 164.27 K | $5.38 M | 14.55% | 0.25% |
| NORGES BANK | 08/12/2026 | 163.20 K | $5.34 M | 100.00% | 0.25% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 146.40 K | $4.79 M | 2.52% | 0.22% |
| DAFNA CAPITAL MANAGEMENT LLC | 08/14/2026 | 130.88 K | $4.28 M | 0.00% | 0.20% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Stoke Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 246 institutional investors and hedge funds held shares of Stoke Therapeutics Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 5.88 M
RTW INVESTMENTS, LP: 5.62 M
FMR LLC: 5.31 M
Lynx1 Capital Management LP: 4.04 M
Redmile Group, LLC: 3.95 M
WELLINGTON MANAGEMENT GROUP LLP: 3.52 M
116.21% of Stoke Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 109.70 M shares in the last 24 months. This purchase volume represents approximately $4.20 B in transactions.